Loading...
Docoh

Biondvax Pharmaceuticals (BVXV)

News

From Benzinga Pro
12 Health Care Stocks Moving In Friday's After-Market Session
13 May 22
Movers
Gainers Trevena (NASDAQ:TRVN) shares moved upwards by 13.3% to $0.23 during Friday's after-market session. The market value of their outstanding shares is at $38.0 million. As per the news, the Q1 earnings report came out 2 days ago.
BVXV: Definitive Collaboration Agreement Signed to Develop Pipeline of NanoAb Therapies…
7 May 22
Penny Stocks
By David Bautz, PhD NASDAQ:BVXV READ THE FULL BVXV RESEARCH REPORT
80 Biggest Movers From Yesterday
4 May 22
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers Blue Water Vaccines, Inc. (NASDAQ: BWV) shares jumped 93.1% to close at $6.45 on Tuesday on above-average volume.
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
19 Apr 22
Pre-Market Outlook, Markets, Movers
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
5 Apr 22
Pre-Market Outlook, Markets, Movers
12 Health Care Stocks Moving In Friday's Pre-Market Session
25 Mar 22
Pre-Market Outlook, Markets, Movers
34 Stocks Moving in Friday's Pre-Market Session
25 Mar 22
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers Clever Leaves Holdings Inc. (NASDAQ: CLVR) rose 40.5% to $2.22 in pre-market trading after the company reported better-than-expected Q4 sales results and reaffirmed FY22 guidance.
63 Biggest Movers From Yesterday
25 Mar 22
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers InMed Pharmaceuticals Inc. (NASDAQ: INM) shares gained 39.1% to close at $1.05 on Thursday. The company recently said its CFO Bruce Colwill will retire.
12 Health Care Stocks Moving In Thursday's Intraday Session
24 Mar 22
Intraday Update, Markets, Movers
Here's Why Biondvax Pharmaceuticals Shares Are Rising
24 Mar 22
Penny Stocks, Movers, Trading Ideas
Biondvax Pharmaceuticals Ltd - ADR (NASDAQ: BVXV) shares are trading higher by 32.1% at $1.81 after the company announced it signed a definitive collaboration agreement for the development of a pipeline of innovative nanosized antibody therapies.
Why Are BiondVax Pharma Shares Gaining Today?
24 Mar 22
Biotech, News, Penny Stocks, Health Care, Contracts, Movers, Trading Ideas, General
BiondVax Pharmaceuticals Ltd (NASDAQ: BVXV) has
12 Health Care Stocks Moving In Thursday's Pre-Market Session
24 Mar 22
Pre-Market Outlook, Markets, Movers
The Daily Biotech Pulse: Novartis Prostate Cancer Drug Lands FDA Approval, Ligand Announces SPAC Deal To Spin Off Antibody Business, Lilly's Lung Cancer Therapy Hit With CRL
24 Mar 22
Biotech, News, Penny Stocks, Offerings, Small Cap, FDA, General
Here's a roundup of top developments in the biotech space over the last 24 hours:
Biondvax Signed Definitive Collaboration Agreement for the Development of a Pipeline of Innovative Nanosized Antibody (Nanoab) Therapies
24 Mar 22
News, Penny Stocks
BiondVax Pharmaceuticals Ltd.
Stocks That Hit 52-Week Lows On Tuesday
22 Feb 22
News, Options, Intraday Update, Markets, Movers, Trading Ideas
During Tuesday's trading, 505 companies set new 52-week lows.

Press releases

From Benzinga Pro
BiondVax to Present at H.C. Wainwright Global Investment Conference
19 May 22
Press Releases
JERUSALEM, May 19, 2022 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative products for the prevention and
BiondVax Provides Update at Biomed Israel Conference and Announces Significant Progress in its Nanosized Antibodies Program
12 May 22
Press Releases
JERUSALEM, May 12, 2022 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative products for the prevention and
BiondVax to Present at this week's Biomed Israel Conference
9 May 22
Press Releases
JERUSALEM , May 9, 2022 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative products for the prevention and
BiondVax to host a Hebrew-language analyst and investor webinar on April 6th
5 Apr 22
Small Cap, Press Releases
JERUSALEM, April 5, 2022 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative products for the prevention and
BiondVax to host analyst and investor webinar on April 4th
31 Mar 22
Small Cap, Press Releases
JERUSALEM, March 31, 2022 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative products for the prevention and
BiondVax Announces Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
28 Mar 22
Earnings, Press Releases
JERUSALEM, March 28, 2022 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative products for the prevention and
Thinking about buying stock in Nikola Corp, D-Market Electronic Services, Biondvax Pharmaceuticals, Trip.com, or Spectrum Pharmaceuticals?
24 Mar 22
Small Cap, Opinion, Press Releases
NEW YORK, March 24, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for NKLA, HEPS, BVXV, TCOM, and SPPI.
BiondVax signs definitive collaboration agreement for the development of a pipeline of innovative nanosized antibody (NanoAb) therapies
24 Mar 22
News, Contracts, Small Cap, Press Releases
JERUSALEM, March 24, 2022 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative products for the prevention and
European Investment Bank Agrees in Principle to Extend the Maturity of its Loan until December 2027 with Additional Terms that Provide Continued Long-Term Support for BiondVax's New Strategy
14 Mar 22
News, Contracts, Press Releases
JERUSALEM, March 14, 2022 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV) announced today that it had been negotiating with the European Investment Bank (the "EIB") terms of restructuring of its
BiondVax to Present at Aegis Virtual Conference
22 Feb 22
Press Releases
JERUSALEM, Feb. 22, 2022 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative products for the prevention and